PERNO, CARLO FEDERICO
PERNO, CARLO FEDERICO
Dipartimento di Oncologia ed Emato-Oncologia
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study
2016 S. Nozza, A.R. Pignataro, L. Galli, V. Svicher, C. Alteri, E. Boeri, M. Ripa, A. Castagna, M. Sampaolo, M. Clementi, C.F. Perno, A. Lazzarin
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
2022 C. Alteri, V. Fox, R. Scutari, G.J. Burastero, S. Volpi, M. Faltoni, V. Fini, A. Granaglia, S. Esperti, A. Gallerani, V. Costabile, B. Fontana, E. Franceschini, M. Meschiari, A. Campana, S. Bernardi, A. Villani, P. Bernaschi, C. Russo, G. Guaraldi, C. Mussini, C.F. Perno
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy
2015 M. Pollicita, C. Alteri, M. Bellocchi, D. Armenia, L. Carioti, R. Salpini, L. Colagrossi, A. Battisti, M. Aragri, L. Fabeni, R. Mariani, M. Dalessandro, A. Ranelli, M. Paoloni, G. Parruti, C. Perno, V. Svicher
Additional mutations in HIV-1 reverse transcriptase involved in regulation of NNRTI resistance
2006 V. Svicher, T. Sing, M.M. Santoro, A. Bertoli, F. Forbici, A. Artese, A. d' Arminio Monforte, A. Antinori, C.F. Perno, F. Ceccherini Silberstein
An update on integrase inhibitors : new opportunities for a personalized therapy? The NEXTaim Project
2015 M. Andreoni, S. Marcotullio, V. Puro, G. De Carli, G. Tambussi, S. Nozza, A. Gori, S. Rusconi, M.M. Santoro, M. Clementi, C.F. Perno, A. d'Arminio Monforte, F. Maggiolo, A. Castagna, A. De Luca, M. Galli, A. Giacomelli, M. Borderi, G. Guaraldi, A. Calcagno, G. Di Perri, S. Bonora, C. Mussini, A. Di Biagio, M. Puoti, R. Bruno, V. Zuccaro, A. Antinori, P. Cinque, D. Croce, U. Restelli, G. Rizzardini, A. Lazzarin
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen
2013 V. Cento, F. Van Hemert, M. Neumann-Fraune, C. Mirabelli, V. Di Maio, R. Salpini, A. Bertoli, V. Micheli, G. Gubertini, S. Romano, M. Visca, G. De Sanctis, B. Berkhout, N. Marino, F. Mazzotta, G. Cappiello, A. Spanò, C. Sarrecchia, F. Ceccherini-Silberstein, M. Andreoni, M. Angelico, J. Verheyen, C.F. Perno, V. Svicher
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial : Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
2016 S. Lambert-Niclot, E.C. George, A. Pozniak, E. White, C. Schwimmer, H. Jessen, M. Johnson, D. Dunn, C.F. Perno, B. Clotet, A. Plettenberg, A. Blaxhult, L. Palmisano, L. Wittkop, V. Calvez, A.G. Marcelin, F. Raffi, N. Dedes, G. Chěne, C. Allavena, B. Autran, A. Antinori, R. Bucciardini, S. Vella, A. Horban, J. Arribas, A.G. Babiker, M. Boffito, D. Pillay, A. Pozniak, X. Franquet, S. Schwarze, J. Grarup, A. Fischer, L. Richert, C. Wallet, F. Raffi, A. Diallo, J. Molina, J. Saillard, C. Moecklinghoff, H. Stellbrink, R. Van Leeuwen, J. Gatell, E. Sandstrom, M. Flepp, F. Ewings, E.C. George, F. Hudson, G. Pearce, R. Quercia, F. Rogatto, R. Leavitt, B. Nguyen, F. Goebel, S. Marcotullio, N. Kaur, P. Sasieni, C. Spencer-Drake, T. Peto, V. Miller, F. Arnault, C. Boucherie, D. Jean, V. Paniego, F. Paraina, E. Rouch, C. Schwimmer, M. Soussi, A. Taieb, M. Termote, G. Touzeau, A. Cursley, W. Dodds, A. Hoppe, I. Kummeling, F. Pacciarini, N. Paton, C. Russell, K. Taylor, D. Ward, B. Aagaard, M. Eid, D. Gey, B.G. Jensen, M. Jakobsen, P.O. Jansson, K. Jensen, Z.M. Joensen, E.M. Larsen, C. Pahl, M. Pearson, B.R. Nielsen, S.S. Reilev, I. Christ, D. Lathouwers, C. Manting, B.Y. Mendy, A. Metro, S. Couffin-Cadiergues, A. Knellwolf, L. Palmisiano, E. Aznar, C. Barea, M. Cotarelo, H. Esteban, I. Girbau, B. Moyano, M. Ramirez, C. Saiz, I. Sanchez, M. Yllescas, A. Binelli, V. Colasanti, M. Massella, O. Anagnostou, V. Gioukari, G. Touloumi, B. Schmied, A. Rieger, N. Vetter, S. De Wit, E. Florence, L. Vandekerckhove, J. Gerstoft, L. Mathiesen, C. Katlama, A. Cabie, A. Cheret, M. Dupon, J. Ghosn, P. Girard, C. Goujard, Y. Lévy, P. Morlat, D. Neau, M. Obadia, P. Perre, J. Reynes, P. Tattevin, J.M. Ragnaud, L. Weiss, Y. Yazdan, P. Yeni, D. Zucman, G. Behrens, S. Esser, G. Fätkenheuer, C. Hoffmann, H. Jessen, J. Rockstroh, R. Schmidt, C. Stephan, S. Unger, A. Hatzakis, G.L. Daikos, A. Papadopoulos, A. Skoutelis, D. Banhegyi, P. Mallon, F. Mulcahy, M. Andreoni, S. Bonora, F. Castelli, A.D. Monforte, G. Di Perri, M. Galli, A. Lazzarin, F. Mazzotta, T. Carlo, V. Vullo, J. Prins, C. Richter, D. Verhagen, A. Van Eeden, M. Doroana, F. Antunes, F. Maltez, R. Sarmento-Castro, J.G. Garcia, J.L. Aldeguer, B. Clotet, P. Domingo, J.M. Gatell, H. Knobel, M. Marquez, M.P. Miralles, J. Portilla, V. Soriano, M. Tellez, A. Thalme, A. Blaxhult, M. Gisslen, A. Winston, J. Fox, M. Gompels, E. Herieka, M. Johnson, C. Leen, A. Teague, I. Williams, M.A. Boyd, N.F. Møller, E.F.M. Larsen, L. Piroth, V. Le Moing, F.W.N.M. Wit, J. Kowalska, J. Berenguer, S. Moreno, N.J. Müller, E. Török, F. Post, B. Angus, V. Calvez, C. Boucher, S. Collins, D. Dunn, S. Lambert, A. Marcelin, E. White, A. Ammassari, W. Stoehr, R.E. Schmidt, M. Odermarsky, C. Smith, R. Thiébaut, J.I.B. De La Serna, A. Castagna, H. Furrer, A. Mocroft, P. Reiss, V. Fragola, M. Lauriola, R. Murri, P. Nieuwkerk, B. Spire, A. Volny-Anne, B. West, H. Amieva, J.M.L. Codina, M. Braggion, E. Focá
Biotech innovations in the prevention of respiratory infectious diseases
2017 J.V. Cento, S. Barbaliscia, C.F. Perno
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy
2019 L. Fabeni, C. Alteri, G. Berno, R. Scutari, N. Orchi, G. De Carli, A. Bertoli, L. Carioti, C. Gori, F. Forbici, R. Salpini, A. Vergori, R. Gagliardini, S. Cicalini, A. Mondi, C. Pinnetti, L. Mazzuti, O. Turriziani, M. Colafigli, V. Borghi, F. Montella, A. Pennica, M. Lichtner, E. Girardi, M. Andreoni, C. Mussini, A. Antinori, F. Ceccherini-Silberstein, C.F. Perno, M.M. Santoro
Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria
2008 M. Santoro, M. Ciccozzi, C. Alteri, S. Montieri, Alexiev, Dimova, F. CECCHERINI-SILBERSTEIN, D. Beshkov, G. Rezza, C. Perno
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs
2009 C. Alteri, S. Svicher, C. Gori, R. Darrigo, M. Ciccozzi, F. CECCHERINI-SILBERSTEIN, M. Selleri, S. AVIANI BARBACCI, M. Giuliani, P. Elia, P. Scognamiglio, Balzanor, N. Orchi, E. Girardi, C. Perno
Circulation of HIV-1 CRF02_AG among MSM population in central Italy : a molecular epidemiology-based study
2013 M. Giuliani, M.M. Santoro, A. Lo Presti, E. Cella, P. Scognamiglio, A. Lai, A. Latini, L. Fabeni, C. Gori, C. Pinnetti, E. Girardi, C.F. Perno, G. Zehender, M. Ciccozzi
Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract
2017 F. Pica, M. Ciotti, M. Maurici, C. Buè, P. Nardi, G. Lucà, G. Moroni, P. Rogliani, C.F. Perno, A. Volpi
Clinical relevance of genotypic resistance testing today
2016 M.M. Santoro, C.F. Perno
Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02-AG) in Italy
2012 M.M. Santoro, C. Alteri, L. Ronga, P. Flandre, L. Fabeni, F. Mercurio, R. D'Arrigo, C. Gori, G. Palamara, A. Bertoli, F. Forbici, R. Salpini, E. Boumis, V. Tozzi, U. Visco-Comandini, M. Zaccarelli, M. Van Houtte, T. Pattery, P. Narciso, A. Antinori, F. Ceccherini-Silberstein, C.F. Perno
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
2006 G.C. Marchetti, A. Gori, A. Casabianca, M. Magnani, F. Franzetti, M.S. Clerici, C.F. Perno, A. d’Arminio Monforte, M. Galli, L. Meroni
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains
2017 L. Fabeni, G. Berno, J. Fokam, A. Bertoli, C. Alteri, C. Gori, F. Forbici, D. Takou, A. Vergori, M. Zaccarelli, G. Maffongelli, V. Borghi, A. Latini, A. Pennica, C.M. Mastroianni, F. Montella, C. Mussini, M. Andreoni, A. Antinori, C.F. Perno, M.M. Santoro
Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression
2016 I. Lenci, L. Baiocchi, L. Tariciotti, D. Di Paolo, M. Milana, F. Santopaolo, T.M. Manzia, L. Toti, V. Svicher, G. Tisone, C.F. Perno, M. Angelico
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
2016 E. Polilli, V. Cento, U. Restelli, F. Ceccherini-Silberstein, M. Aragri, V.C. Di Maio, A. Sciacca, F. Santoleri, P. Fazii, A. Costantini, C.F. Perno, G. Parruti
Correlation between M36I in HIV protease and selection/maintenance of L90M after treatment with protease inhibitors.
2005 C. Perno, A. Cozzi Lepri, F. Ceccherini Silberstein, A. D'ARMINIO MONFORTE, F. ICONA Study Group